Your browser is no longer supported. Please, upgrade your browser.
ANIK Anika Therapeutics, Inc. daily Stock Chart
ANIK [NASD]
Anika Therapeutics, Inc.
Index- P/E24.56 EPS (ttm)2.16 Insider Own0.80% Shs Outstand14.36M Perf Week-7.53%
Market Cap763.23M Forward P/E32.75 EPS next Y1.62 Insider Trans-22.94% Shs Float13.72M Perf Month-12.19%
Income30.90M PEG2.46 EPS next Q0.42 Inst Own99.30% Short Float15.12% Perf Quarter-2.06%
Sales111.80M P/S6.83 EPS this Y-34.90% Inst Trans-1.65% Short Ratio11.86 Perf Half Y31.17%
Book/sh20.02 P/B2.65 EPS next Y-20.44% ROA10.40% Target Price49.75 Perf Year70.46%
Cash/sh12.06 P/C4.41 EPS next 5Y10.00% ROE11.60% 52W Range29.01 - 75.71 Perf YTD58.14%
Dividend- P/FCF24.38 EPS past 5Y-1.70% ROI6.50% 52W High-29.80% Beta0.99
Dividend %- Quick Ratio17.70 Sales past 5Y7.10% Gross Margin75.80% 52W Low83.21% ATR1.70
Employees133 Current Ratio20.00 Sales Q/Q10.80% Oper. Margin35.10% RSI (14)33.37 Volatility3.63% 2.74%
OptionableYes Debt/Eq0.00 EPS Q/Q21.00% Profit Margin27.60% Rel Volume1.37 Prev Close53.50
ShortableYes LT Debt/Eq0.00 EarningsJan 23 AMC Payout0.00% Avg Volume174.96K Price53.15
Recom2.50 SMA20-7.51% SMA50-10.45% SMA20014.26% Volume240,023 Change-0.65%
Nov-05-19Initiated BWS Financial Sell $29
Sep-24-19Reiterated Barrington Research Outperform $49 → $58
Sep-23-19Downgrade First Analysis Sec Strong Buy → Outperform $54
Jul-25-19Upgrade First Analysis Sec Neutral → Strong Buy $37 → $54
Feb-22-19Downgrade Sidoti Buy → Neutral $56 → $41
Feb-22-19Downgrade First Analysis Sec Outperform → Neutral $41 → $37
Jul-27-18Upgrade Barrington Research Mkt Perform → Outperform $48
Jun-20-18Downgrade First Analysis Sec Overweight → Equal-Weight $45 → $34
Jun-20-18Downgrade Barrington Research Outperform → Mkt Perform
May-04-18Upgrade Barrington Research Mkt Perform → Outperform $39
Feb-23-18Downgrade Barrington Research Outperform → Mkt Perform
Jan-24-18Upgrade First Analysis Sec Equal-Weight → Overweight $45 → $68
Oct-27-17Reiterated Barrington Research Outperform $53 → $57
May-09-16Upgrade Singular Research BUY - Long-Term → Buy $60
Apr-27-16Downgrade Northland Capital Outperform → Market Perform
Feb-26-16Reiterated Barrington Research Outperform $45 → $49
Oct-12-15Initiated Barrington Research Outperform $39
Aug-28-15Initiated First Analysis Sec Equal-Weight
Jul-30-15Reiterated Northland Capital Outperform $56 → $57
May-14-15Initiated Northland Capital Outperform $56
Dec-13-19 09:25AM  Blueprint Medicines (BPMC) Up More Than 30% YTD: Here's Why Zacks
Dec-12-19 03:19PM  ProQR (PRQR) Begins Dosing in Phase I/II Eye Disorder Study Zacks
02:34PM  BioCryst Submits NDA for Hereditary Angioedema Candidate Zacks
09:36AM  Amgen's Osteoporosis Drug Evenity Gets Approval in Europe Zacks
Dec-11-19 04:11PM  Is Anika Therapeutics, Inc. (ANIK) A Good Stock To Buy ? Insider Monkey
02:42PM  Vertex's Kalydeco Gets EU Approval to Treat CF in Infants Zacks
10:06AM  VistaGen Up on Fast Track Designation for Anxiety Disorder Drug Zacks
08:40AM  Intra-Cellular Therapies (ITCI) in Focus: Stock Moves 6.1% Higher Zacks
Dec-10-19 09:26AM  TG Therapeutics' Shares Soar on Positive Early-Stage Data Zacks
08:30AM  Anika Commences Full U.S. Commercial Launch of TACTOSET Bone Repair Therapy at Orthopaedic Summit 2019: Evolving Techniques Business Wire
Dec-09-19 04:31PM  Regeneron Reports Initial Data for Multiple Myeloma Drug Zacks
04:03PM  bluebird Reports Positive Top-Line Data on Myeloma Drug Zacks
08:36AM  Alexion (ALXN) Looks Good: Stock Adds 6% in Session Zacks
Dec-06-19 09:26AM  Sage Therapeutics' Depression Drug Fails in Study, Stock Down Zacks
Dec-05-19 03:53PM  Spero Posts Preliminary Data on SPR720 for Pulmonary Disease Zacks
10:02AM  Ra Pharmaceuticals Begins Phase II Study on Autoimmune Drug Zacks
09:07AM  Zealand Initiates Second Late-Stage CHI Study on Dasiglucagon Zacks
Dec-04-19 10:25AM  Biogen's Lupus Candidate Meets Endpoint in Phase II Study Zacks
Dec-03-19 10:45AM  Seattle Genetics, Astellas Tie Up With Merck for Cancer Study Zacks
09:16AM  Amarin's Vascepa MAA for Heart Risk Indication Accepted in EU Zacks
08:59AM  Puma Biotech Expands Pierre Fabre License to Add Countries Zacks
Dec-02-19 10:22AM  Acorda (ACOR) Down More Than 80% Year to Date: Here's Why Zacks
Nov-28-19 08:10AM  Incyte's NDA for Pemigatinib Gets FDA's Priority Review Tag Zacks
Nov-27-19 09:00AM  Clovis (CLVS) Looks Good: Stock Adds 6.3% in Session Zacks
03:32AM  Sorrento Turns Down Two All-Cash Takeover Bids, Stock Jumps Zacks
03:28AM  Global Blood's (GBT) Oxbryta Secures FDA Approval for SCD Zacks
Nov-25-19 09:18AM  Alexion Gets Approval for Label Expansion of Soliris in Japan Zacks
Nov-22-19 09:45AM  Biogen Ends Enrollment in Eye Disorder Study on Gene Therapy Zacks
Nov-21-19 10:24AM  Vertex (VRTX) Gets French Reimbursement for CF Drug Orkambi Zacks
09:54AM  Alnylam's Givosiran Gets FDA Nod for Acute Hepatic Porphyria Zacks
08:00AM  Daré Bioscience Closes Previously Announced Acquisition of Microchips Biotech with a First-in-Class Wireless, User-Controlled Drug Delivery Platform GlobeNewswire
Nov-20-19 09:50AM  Achillion's (ACHN) Danicopan Gets EMA's PRIME Tag for PNH Zacks
Nov-19-19 09:40AM  Axovant's GM1 Gangliosidosis Candidate Gets Orphan Drug Tag Zacks
09:36AM  Alkermes to Acquire Rodin Therapeutics, Boost CNS Pipeline Zacks
Nov-18-19 05:25PM  Celgene's Revlimid-Rituximab Combo Gets Positive CHMP Opinion Zacks
10:27AM  Medicines Company Posts Full Inclisiran Data From ASCVD Study Zacks
Nov-15-19 10:02AM  VistaGen's (VTGN) Major Depressive Disorder Drug Disappoints Zacks
09:10AM  Amarin (AMRN) Gets FDA Panel Nod for Vascepa Label Expansion Zacks
08:57AM  Sarepta (SRPT) Stock Down Despite New $48M Gene Therapy Deal Zacks
08:30AM  Anika Therapeutics Announces Participation in MEDICA International Trade Fair and International Cartilage Regeneration and Joint Preservation Society Focus Meeting Business Wire
Nov-14-19 10:20AM  BioDelivery (BDSI) Stock Up on Q3 Earnings Beat & Raised View Zacks
09:00AM  QIAGEN (QGEN) Catches Eye: Stock Jumps 9.9% Zacks
08:27AM  Halozyme Therapeutics (HALO) Looks Good: Stock Adds 5.4% in Session Zacks
Nov-13-19 09:05AM  Catalyst's (CPRX) Q3 Earnings Beat Estimates, Sales Miss Zacks
08:00AM  IVERIC bio (ISEE) Q3 Loss Narrows Y/Y, Zimura Advancing Well Zacks
Nov-12-19 09:52AM  Amicus' (FOLD) Shares Rise on Q3 Earnings & Revenue Beat Zacks
Nov-09-19 03:54PM  Here is What Hedge Funds Think About Anika Therapeutics, Inc. (ANIK) Insider Monkey
Nov-08-19 10:08AM  Spectrum Pharma's (SPPI) Q3 Loss Narrows, Focus on Rolontis Zacks
Nov-07-19 11:26AM  PDL BioPharma (PDLI) Q3 Earnings Beat, LENSAR Drives Sales Zacks
11:20AM  Emergent (EBS) Beat Earnings in Q3, Vaccines Drive Sales Zacks
Nov-06-19 11:24AM  Blueprint Medicines (BPMC) Q3 Earnings & Sales Top Estimates Zacks
Nov-05-19 04:05PM  Anika to Showcase Joint Preservation and Restoration Portfolio at the 2019 Fortius International Sports Injury Conference Business Wire -6.17%
11:45AM  Acorda (ACOR) Q3 Earnings and Revenues Surpass Estimates Zacks
Nov-04-19 11:18AM  AMAG Q3 Loss Wider Than Expected, Revenues Lag Estimates Zacks
11:08AM  The Zacks Analyst Blog Highlights: Unifi, BioDelivery Sciences International, Crocs, Anika Therapeutics and Plexus Zacks
05:56AM  Does Anika Therapeutics, Inc. (NASDAQ:ANIK) Have A High Beta? Simply Wall St.
Nov-01-19 02:49PM  Repligen (RGEN) Beats on Q3 Earnings, Lifts 2019 Guidance Zacks
07:45AM  5 Top Momentum Stocks in October That Still Have Upside Left Zacks
Oct-31-19 12:40PM  Immunomedics (IMMU) Reports Wider-Than-Expected Loss in Q3 Zacks
12:33PM  Vertex (VRTX) Q3 Earnings Beat, Revenues Lag Estimates Zacks
Oct-30-19 10:00AM  What Makes Anika Therapeutics (ANIK) a Strong Momentum Stock: Buy Now? Zacks
Oct-29-19 10:27AM  Anika Therapeutics, Inc. (ANIK) Shares March Higher, Can It Continue? Zacks
Oct-25-19 07:12AM  The Daily Biotech Pulse: Melinta Crosses FDA Hurdle But Sees Liquidity Pushback, Positive Readout For Aclaris Wart Drug Benzinga +35.18%
Oct-24-19 06:45PM  Anika Therapeutics (ANIK) Q3 Earnings and Revenues Surpass Estimates Zacks
04:05PM  Anika Reports Third Quarter 2019 Financial Results Business Wire
Oct-18-19 11:17AM  Zacks.com featured highlights include: KB Home, Crocs, NetEase, Taylor Morrison Home and Anika Therapeutics Zacks
Oct-17-19 10:33AM  Analysts Estimate Anika Therapeutics (ANIK) to Report a Decline in Earnings: What to Look Out for Zacks
07:24AM  5 Stocks With Recent Price Strength Despite Trade Jitters Zacks
Oct-16-19 08:30AM  Anika to Showcase Joint Preservation and Restoration Portfolio at the Annual Scientific Meeting of the International Society for Hip Arthroscopy Business Wire
Oct-14-19 08:30AM  Anika Appoints Mira Leiwant as Vice President of Regulatory Affairs, Quality, and Clinical Affairs Business Wire
Oct-10-19 04:05PM  Anika to Issue Third-quarter 2019 Financial Results and Business Highlights on Thursday, October 24 Business Wire
Oct-04-19 08:52AM  Constellation Pharmaceuticals (CNST) Looks Good: Stock Adds 8.3% in Session Zacks
08:30AM  Anika to Showcase Joint Preservation and Restoration Portfolio at the 2019 World Congress of the International Cartilage Regeneration and Joint Preservation Society Business Wire
Oct-03-19 08:41AM  Axsome (AXSM) Catches Eye: Stock Jumps 9.3% Zacks
08:39AM  AnaptysBio (ANAB) Looks Good: Stock Adds 8.1% in Session Zacks
08:37AM  Apellis Pharmaceuticals (APLS) Catches Eye: Stock Jumps 5.2% Zacks
Sep-30-19 04:50PM  5 Companies With Positive Earnings Growth Estimates GuruFocus.com
Sep-29-19 08:50AM  If You Had Bought Anika Therapeutics (NASDAQ:ANIK) Shares Five Years Ago You'd Have Made 41% Simply Wall St.
Sep-26-19 08:30PM  Link to Amazon Could Boost Semtech Shares Barrons.com
09:30AM  Has Anika Therapeutics (ANIK) Outpaced Other Medical Stocks This Year? Zacks
09:00AM  Anika (ANIK) Upgraded to Strong Buy: What Does It Mean for the Stock? Zacks
08:35AM  Why Avid Bioservices (CDMO) Could Be Positioned for a Slump Zacks
Sep-18-19 08:30AM  Anika Commences U.S. Commercial Launch of TACTOSET Bone Repair Therapy Under Its New U.S. Hybrid Commercial Model Business Wire
Sep-04-19 04:05PM  Anika Therapeutics to Host Analyst and Investor Day on September 18, 2019 Business Wire
Sep-03-19 04:05PM  Anika to Participate in the 2019 Morgan Stanley Global Healthcare Conference on September 10, 2019 Business Wire
Aug-23-19 02:12PM  Here's What Anika Therapeutics, Inc.'s (NASDAQ:ANIK) P/E Is Telling Us Simply Wall St.
Aug-13-19 08:30AM  Anika Announces Successful Completion of First Human Surgical Procedure with Injectable HA-Based Bone Repair Therapy Business Wire
Jul-29-19 09:55AM  Anika Therapeutics Gets a Quant Upgrade to Buy, Adding to Its Technical Breakout TheStreet.com
Jul-26-19 11:17AM  Harry Boxers four stock breakouts to watch MarketWatch +6.18%
11:06AM  4 Earnings Breakouts To Watch Benzinga
07:26AM  The Daily Biotech Pulse: Obseva Gets The Greenlight, Verastem Climbs On Licensing Deal, Merit Medical Earnings Disappoint Benzinga
Jul-25-19 04:31PM  Why Anika Therapeutics Stock Crushed It Today Motley Fool +28.86%
07:21AM  The Daily Biotech Pulse: Setback For Bristol-Myers Squibb, Gemphire Explodes, Lilly's Nasal Low Blood Sugar Drug Benzinga
06:29AM  Anika Therapeutics Blows Past Q2 Earnings Estimates Motley Fool
12:24AM  Anika Therapeutics Inc (ANIK) Q2 2019 Earnings Call Transcript Motley Fool
Jul-24-19 06:35PM  Anika Therapeutics (ANIK) Q2 Earnings and Revenues Surpass Estimates Zacks
04:05PM  Anika Reports Second Quarter 2019 Financial Results Business Wire
Jul-22-19 11:13AM  What's in Store for Anika Therapeutics' (ANIK) Q2 Earnings? Zacks
Jul-18-19 12:46PM  Is Anika Therapeutics, Inc.'s (NASDAQ:ANIK) 11% ROE Worse Than Average? Simply Wall St.
Jul-17-19 10:32AM  Analysts Estimate Anika Therapeutics (ANIK) to Report a Decline in Earnings: What to Look Out for Zacks
Anika Therapeutics, Inc., together with its subsidiaries, provides orthopedic medicines for patients with degenerative orthopedic diseases and traumatic conditions in the United States and internationally. The company develops, manufactures, and commercializes therapeutic products based on its proprietary hyaluronic acid (HA) technology. Its orthobiologics products comprise ORTHOVISC, ORTHOVISC mini, MONOVISC, and CINGAL for the treatment of osteoarthritis of the knee; HYALOFAST, a biodegradable support for human bone marrow mesenchymal stem cells used for cartilage regeneration and as an adjunct for microfracture surgery; HYALONECT, a resorbable knitted fabric mesh; HYALOSS MATRIX, HYAFF fibers used to mix blood/bone grafts to form a paste for bone regeneration; and HYALOGLIDE, an ACP gel used in tenolysis treatment. The company's dermal products include wound care products that comprise HYALOMATRIX and HYALOFILL for the treatment of complex wounds, such as burns and ulcers, and for use in connection with the regeneration of skin; and ELEVESS, an aesthetic dermatology product. Its surgical products comprise HYALOBARRIER, a post-operative adhesion barrier for use in the abdomino-pelvic area; MEROGEL, a woven fleece nasal packing; and MEROGEL INJECTABLE, a viscous hydrogel. The company also offers ophthalmic products, including injectable HA products that are used as viscoelastic agents in ophthalmic surgical procedures, such as cataract extraction and intraocular lens implantation; and veterinary products, which include HYVISC, an injectable HA product for the treatment of joint dysfunction in horses. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cheung SylviaChief Financial OfficerNov 08Sale59.7120,0001,194,20047,741Nov 08 05:40 PM
Cheung SylviaChief Financial OfficerNov 06Option Exercise6.3635,000222,60071,422Nov 08 05:40 PM
Larsen Glenn R.DirectorAug 28Sale57.214,355249,1507,590Aug 30 04:05 PM
Bower Joseph L.DirectorAug 20Sale55.571,994110,80743,010Aug 22 04:05 PM
Thompson Jeffery SDirectorAug 08Sale56.664,843274,4046,842Aug 12 04:06 PM
LAND RAYMOND JDirectorJul 29Sale55.443,000166,32011,992Jul 30 04:06 PM
Darling Joseph GPresident and CEO; DirectorFeb 28Buy33.201,00033,20022,436Mar 01 08:30 AM
LAND RAYMOND JDirectorFeb 26Sale33.064,000132,24014,992Feb 28 04:34 PM